Peritoneal dialysis is one of the methods of extracellular blood purification. Peritoneal dialysis uses numerous folds of the peritoneum as a filter. Dialysis fluid is introduced into the abdominal cavity with a catheter in the lower abdominal wall. A catheter is known as a dialysis catheter.

Peritoneal dialysis eliminates metabolic products when the kidneys are not functioning properly, as well as toxic substances such as excess endogenous fluids that are released by the kidneys if their functioning is normal. In addition, peritoneal dialysis helps correct electrolyte imbalances to reduce swelling.

Link-Medital supplies quality healthcare products and medicines to recognized healthcare providers from the renowned German manufacturer Fresenius.

We make every effort to ensure that as many patients with renal failure as possible receive quality and effective treatment.

Hemophilia is a genetic disease caused by congenital blood coagulation factor protein deficiency. Mainly for the prevention of hemophilia used substitution therapy - the regular introduction of drugs containing the missing protein - a factor in blood clotting.

Link-Medital supplies the highest blood clotting factors for the healthcare industry to companies named Baxter. The most famous drugs - Immunate, Immune, Recombinate, Feiba - anti-inhibitory coagulant complex.

In addition to blood factors, Link-Medital provides healthcare facilities and other immunobiological preparations - human normal immunoglobulin, human albumin and more.

The company, for its part, always makes every effort to ensure that Ukrainian patients receive high-quality immunobiological preparations on time, with strict compliance with the requirements for safety and quality of products.

Orphan diseases are rare congenital or acquired diseases that are characterized by a severe, chronic, progressive course, accompanied by the formation of degenerative changes in the body, decreased quality and shortened life expectancy of patients, and even pose a threat to their lives. People with Orphan Diseases usually require costly, continuous, and lifelong treatment. Most orphan diseases are diagnosed at an early age, in 35 % of cases they cause infant death by the year, in 10 % - children under 5 years of age, in 12 % - in the age of 5 to 15 years.

In view of the patients' needs, Link-Medital is making every effort to develop this area by planning to provide healthcare facilities with the highest quality medicines, including for the treatment of primary immunodeficiencies, Anderson-Fabry disease, mucopolysaccharidosis, juvenile rheumatoid arthritis.